[June 29, 2011]

Lieff, Cabraser, Heimann & Bernstein, LLP Announces Class Action Lawsuits Against Computer Sciences Corporation

The law firm of Lieff, Cabraser, Heimann & Bernstein, LLP is investigating potential illegal conduct as alleged in class action lawsuits brought on behalf of all purchasers of the common stock of Computer Sciences (News - Alert) Corporation ("CSC" or the "Company") (NYSE: CSC) between August 11, 2010 and May 25, 2011, inclusive (the "Class Period").

If you purchased CSC (News - Alert) common stock during the Class Period, you may move the Court for appointment as lead plaintiff by no later than August 2, 2011.  A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.  Your share of any recovery in the action will not be affected by your decision of whether to seek appointment as lead plaintiff.  You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.

CSC shareholders who wish to learn more about the action and how to seek appointment as lead plaintiff should click here or contact Sharon Lee of Lieff Cabraser toll free at (800) 541-7358.

Background on the CSC Securities Class Litigation

The actions are brought against CSC and certain of its officers and directors for violatios of the Securities Exchange Act of 1934.  CSC, headquartered in Falls Church, Virginia, provides information technology and business process outsourcing, as well as information technology and professional services to the commercial and government markets.

The complaints allege that during the Class Period, defendants misrepresented and/or omitted material information regarding the Company's financial condition and prospects.  Specifically, defendants allegedly failed to adequately disclose 1) accounting problems with respect to the financial results from CSC's Managed Services Sector ("MSS"), 2) CSC's contract with the United Kingdom's National Health Service ("NHS") was at risk of being terminated due to CSC's failure to meet a key performance milestone under the contract, and 3) CSC was experiencing a slowdown in demand for its products and services.  As a result of the foregoing, there was no reasonable basis in fact for the fiscal 2011 guidance issued by defendants during the Class Period. 

On February 1, 2011, CSC issued a press release announcing that the SEC (News - Alert) had launched a formal investigation into accounting irregularities at the Company. 

On February 9, 2011, CSC reported disappointing third quarter 2011 results and lowered its guidance for the year, citing a slowdown in U.S. government contracts, accounting problems in its MSS business, and the failure to meet a milestone under the NHS contract.  On this news, the price of CSC shares fell $8.11 per share, or 14.3 percent, to close at $48.43 on extremely high trading volume.

On May 2, 2011, the Company announced its fourth quarter 2011 financial results and reported that it was nearing an agreement with NHS on a revised contract and updated its fiscal 2011 guidance, announcing that it would miss its reduced fiscal 2011 revenue expectations by $100 million and its earnings expectations by $0.45 per share.  Following this announcement, the price of CSC shares fell another $6.52 per share, or 12.9 percent, to close at $44.03, on unusually high trading volume.

On May 25, 2011, after the market closed, the Company pre-announced its fourth quarter and fiscal 2011 financial results.  The Company reported, among other things, fourth quarter 2011 earnings results of $1.09 per share, which missed Wall Street consensus estimates of $1.16, and that fiscal 2011 earnings would be below the Company's recent reduced forecast of $4.75 per share.  In addition, the Company also disclosed that its Audit Committee had begun an internal investigation into accounting irregularities in one of its service sectors.  On this news, CSC's stock price fell $5.71 per share, or 12 percent, to close at $38.38 per share.

About Lieff Cabraser

Lieff, Cabraser, Heimann & Bernstein, LLP, with offices in San Francisco, New York and Nashville, is a nationally recognized law firm committed to advancing the rights of investors and promoting corporate responsibility.

Since 2003, the National Law Journal has selected Lieff Cabraser as one of the top plaintiffs' law firms in the nation.   In compiling the list, the National Law Journal examined recent verdicts and settlements in addition to overall track records. Lieff Cabraser is one of only two plaintiffs' law firms in the United States to receive this honor for the last eight consecutive years.

For more information about Lieff Cabraser and the firm's representation of investors, please visit http://www.lieffcabraser.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

[ Back To TMCnet.com's Homepage ]